Using novel point-of-care diagnostic tests and mathematical modelling to achieve hepatitis B elimination: The Rapid B Study

The Rapid B Study will use mathematical modelling to determine the most cost-effective approach to testing and treatment of hepatitis B. We will model the health impact, cost and cost effectiveness of 1) a POC test-led treatment in accordance with current guidelines strategy and 2) a POC test-led treat-all strategy compared to current standard of care in five countries with diverse hepatitis B disease burdens and national income levels.